Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
spastic paraplegia 37 (autosomal dominant) | 1.000 | 0.077 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
spastic paraplegia 38 (autosomal dominant, Silver syndrome) | 0.890 | 0.115 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 | 0.576 | 0.654 | 0.76 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ectodysplasin A receptor | 0.623 | 0.423 | 1.3E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
trehalase | 0.670 | 0.654 | 9.0E-15 |
|
disease | 0.600 | None | 0 | 0 | |||||||||||
|
ring finger protein 139 | 0.670 | 0.423 | 0.54 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
sodium voltage-gated channel alpha subunit 11 | 0.666 | 0.462 | 6.9E-26 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
sodium voltage-gated channel alpha subunit 11 | 0.666 | 0.462 | 6.9E-26 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
sodium voltage-gated channel alpha subunit 11 | 0.666 | 0.462 | 6.9E-26 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
Parkinsonism associated deglycase | 0.535 | 0.808 | 0.75 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
EDAR associated death domain | 0.638 | 0.462 | 3.2E-04 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
collagen type VII alpha 1 chain | 0.545 | 0.808 | 2.4E-40 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
collagen type VII alpha 1 chain | 0.545 | 0.808 | 2.4E-40 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
collagen type XVII alpha 1 chain | 0.545 | 0.769 | 2.3E-27 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
CD109 molecule | 0.595 | 0.654 | 2.3E-44 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
CRK like proto-oncogene, adaptor protein | 0.553 | 0.769 | 0.45 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
spastic paraplegia 19 (autosomal dominant) | 0.931 | 0.077 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
catenin delta 2 | 0.579 | 0.731 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cytochrome P450 family 11 subfamily B member 2 | 0.553 | 0.615 | 7.1E-19 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
disease | 0.300 | None | 0 | 0 |